Expertise in
3
conditions

Peeter Karihtala

Helsinki, FI 
Expertise in
3
conditions
Helsinki, FI 

Overview

Peeter Karihtala practices practicing medicine in Helsinki, Finland.

Karihtala is highly rated in 3 conditions, according to our data. Their clinical expertise encompasses Breast Cancer, HER-2 Positive Breast Cancer, Febrile Neutropenia, and Diffuse Large B-Cell Lymphoma (DLBCL).

They are actively involved in clinical research, co-authoring 134 peer reviewed articles and participating in 1 clinical trial.

Locations

Helsinki, Finland
Other Locations
Oulu, Finland
Box, 00029, Finland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone in Patients With High Risk, Node Positive, Early Stage, Hormone Receptor Positive, Human Epidermal Receptor 2 Negative, Breast Cancer
A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone in Patients With High Risk, Node Positive, Early Stage, Hormone Receptor Positive, Human Epidermal Receptor 2 Negative, Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: April 24, 2026
Intervention Type: Drug
Study Drugs: Abemaciclib, Standard Adjuvant Endocrine Therapy
Study Phase: Phase 3

134 Total Publications

CDK4/6 inhibitor dose patterns among older patients with metastatic breast cancer: A multinational survey study.
CDK4/6 inhibitor dose patterns among older patients with metastatic breast cancer: A multinational survey study.
Journal: Journal of geriatric oncology
Published: November 25, 2025

Frequently Asked Questions about Peeter Karihtala

Is Peeter Karihtala a top-rated expert for Breast Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Peeter Karihtala is classified as an Advanced expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Peeter Karihtala participate in research or clinical trials?

Yes. Peeter Karihtala has published 134 articles and abstracts on conditions like Breast Cancer. You can view a list of Peeter Karihtala's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Karihtala's expertise for a condition
ConditionClose
      View All 22 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile